Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway
Cellular Oncology · 2025-06 · 48 (3) · 743-760
DOI: 10.1007/s13402-025-01044-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 14.04.2025. Verfasst von Xinyu Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Lushan Road N…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hypoxia-Inducible Factor 1, alpha Subunit, Sorafenib, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Laboratory Open Fund of Changsha Maternal and Child Hospital, National Natural Science Foundation of China, Key grant of research and development in Hunan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Lushan Road No. 14, Changsha, 410081, China.
- Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410013, China.
- College of Engineering and Design, Hunan Normal University, Taozihu Road No. 68, Changsha, 410081, China. hncslilimin@hunnu.edu.cn.
- Department of Neurosurgery, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.
- Department of Hepatobiliary and Pancreatic Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.
- Department of Physics, Department of Materials Science and Engineering, and Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China.
Förderung
- Key Laboratory Open Fund of Changsha Maternal and Child Hospital
- National Natural Science Foundation of China
- Key grant of research and development in Hunan Province
- Natural Science Foundation in Hunan Province
- Key project of Hunan Provincial Education Department
- Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province
Zitieren
APA
Zhu, X., Li, Z., Chen, L., Li, L., Ouyang, M., Zhou, H., Xiao, K., Lin, L., Chu, P. K., Zhou, C., Xun, C., Yang, L., Huang, W., & Ding, X. (2025). Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway. Cellular Oncology, 48(3), 743-760. https://doi.org/10.1007/s13402-025-01044-x
Vancouver
Zhu X, Li Z, Chen L, Li L, Ouyang M, Zhou H, et al. Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway. Cellular Oncology. 2025;48(3):743-760. doi:10.1007/s13402-025-01044-x
BibTeX
@article{Zhu2025,
author = {Zhu, Xinyu and Li, Zhiwei and Chen, Li and Li, Limin and Ouyang, Mi and Zhou, Hao and Xiao, Kai and Lin, Ling and Chu, Paul K and Zhou, Chang and Xun, Chengfeng and Yang, Liu and Huang, Wenhuan and Ding, Xiaofeng},
title = {Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway},
journal = {Cellular Oncology},
year = {2025},
volume = {48},
number = {3},
pages = {743--760},
doi = {10.1007/s13402-025-01044-x}
}
EUVIMED